Warner Chilcott added to the U.S. Key Call list at UBS UBS believes the Street is underestimating Warner Chilcott's oral contraceptive and gastroenterology franchises and sees shares driven by strong free cash flow yield. Shares are Buy rated.
News For WCRX From The Last 14 Days
Check below for free stories on WCRX the last two weeks.
